A 2009 Norwegian study published in the Journal of the National Cancer Institute reveals that of 1,402 men treated for testicular cancer, 29 percent reported hearing impairment and 22 percent reported tinnitus.
These were reported as major symptoms troubling them either quite a bit or very much from between 4 to 21 years after such cancer treatment.
Long-term issues with hearing loss and tinnitus seemed to affect those men who had received high-dose cisplatin-based chemotherapy. Those who smoked on a daily basis were also more likely to be affected than men in the study who had never smoked.
Source: Journal of the National Cancer Institute, November 25, 2009. Reported by Reuters
Comments
Post a Comment